1. Home
  2. EARN vs CBUS Comparison

EARN vs CBUS Comparison

Compare EARN & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • CBUS
  • Stock Information
  • Founded
  • EARN 2012
  • CBUS 2010
  • Country
  • EARN United States
  • CBUS United States
  • Employees
  • EARN N/A
  • CBUS N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • CBUS Agricultural Chemicals
  • Sector
  • EARN Real Estate
  • CBUS Industrials
  • Exchange
  • EARN Nasdaq
  • CBUS Nasdaq
  • Market Cap
  • EARN 177.0M
  • CBUS 160.8M
  • IPO Year
  • EARN 2013
  • CBUS 2017
  • Fundamental
  • Price
  • EARN $6.95
  • CBUS $5.00
  • Analyst Decision
  • EARN Hold
  • CBUS Strong Buy
  • Analyst Count
  • EARN 2
  • CBUS 3
  • Target Price
  • EARN $6.00
  • CBUS $23.67
  • AVG Volume (30 Days)
  • EARN 371.1K
  • CBUS 137.1K
  • Earning Date
  • EARN 08-12-2024
  • CBUS 08-08-2024
  • Dividend Yield
  • EARN 13.86%
  • CBUS N/A
  • EPS Growth
  • EARN 102.38
  • CBUS N/A
  • EPS
  • EARN 0.23
  • CBUS N/A
  • Revenue
  • EARN $18,419,000.00
  • CBUS $2,961,000.00
  • Revenue This Year
  • EARN N/A
  • CBUS $36.93
  • Revenue Next Year
  • EARN $51.24
  • CBUS $236.45
  • P/E Ratio
  • EARN $29.84
  • CBUS N/A
  • Revenue Growth
  • EARN N/A
  • CBUS 816.72
  • 52 Week Low
  • EARN $5.09
  • CBUS $4.26
  • 52 Week High
  • EARN $7.26
  • CBUS $23.18
  • Technical
  • Relative Strength Index (RSI)
  • EARN 49.75
  • CBUS 35.69
  • Support Level
  • EARN $6.85
  • CBUS $4.77
  • Resistance Level
  • EARN $6.95
  • CBUS $5.50
  • Average True Range (ATR)
  • EARN 0.09
  • CBUS 0.65
  • MACD
  • EARN 0.00
  • CBUS -0.05
  • Stochastic Oscillator
  • EARN 46.87
  • CBUS 26.61

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: